Clinical trial
E-Selectin Nasal Instillation to Prevent Secondary Stroke
NCT00069069 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Withdrawn
Key facts
| NCT number | NCT00069069 |
|---|---|
| Title | E-Selectin Nasal Instillation to Prevent Secondary Stroke |
| Official title | Induction of Mucosal Tolerance to Human E-Selectin for the Secondary Prevention of Stroke |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ischemic Attack, Transient |
| Intervention type | Drug |
| Interventions | Intransal instillation of E-selectin |
| Enrollment | 0 |
| Start date | Oct 1, 2003 |
| Primary completion | May 9, 2018 |
| Completion | May 9, 2018 |
| First posted | Sep 15, 2003 |
| Last update posted | Jul 5, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: